Ginkgo Bioworks (DNA) Misses Q3 EPS by 7c

Ginkgo Bioworks (NYSE: DNA) reported Q3 EPS of ($0.16), $0.07 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $55.43 million versus the consensus estimate of $48.08 million.

For earnings history and earnings-related data on Ginkgo Bioworks (DNA) click here.

You May Also Be Interested In

• BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
• Bending Spoons S.p.A. (BSP) Tops Q2 EPS by 19c; offers guidance
• ADC Therapeutics SA (ADCT) Tops Q2 EPS by 11c